Cystic Fibrosis Foundation Invests More Than $6.6 Million in Additional Funding in Sionna Therapeutics
March 08, 2024
March 08, 2024
BETHESDA, Maryland, March 8 -- Cystic Fibrosis Foundation issued the following news release:
The Cystic Fibrosis Foundation has invested more than $6.6 million in additional funding in Sionna Therapeutics to continue research into the development of potential new modulator therapies that could provide alternatives to others already on the market.
Sionna has been testing various compounds that could form a potential modulator therapy. Two are in Phase 1 clinical trials, . . .
The Cystic Fibrosis Foundation has invested more than $6.6 million in additional funding in Sionna Therapeutics to continue research into the development of potential new modulator therapies that could provide alternatives to others already on the market.
Sionna has been testing various compounds that could form a potential modulator therapy. Two are in Phase 1 clinical trials, . . .